Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-03-22FDA Approved: REPAGLINIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original Abbreviated New Drug Application for repaglinide, a meglitinide used to improve gly…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Phase 1 trial updating tirzepatide in participants with type 2 diabetes mellitus has completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity. [Phase 4]
Phase 4 trial comparing glucose control and weight loss effects between Beinaglutide and Dulaglutide in adults with type 2 diabetes and over…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM [Phase 3]
Phase 3 trial evaluating REX-001 for ischemic ulcers in patients with Critical Limb Ischemia (CLI) and diabetes was terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2 [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating glycemic control using GlucoTab with insulin degludec in hospitalized patients with type 2 diab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Investigational Study of Delayed Release Metformin [Phase 3]
Phase 3 trial of delayed-release metformin for type 2 diabetes is currently suspended.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue [Phase 3]
A Phase 3 trial comparing basal-bolus insulin against basal insulin plus a GLP-1 analogue assessing hypoglycemia risk during transition from…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients [Phase 4]
Phase 4 clinical trial investigating NT-proBNP-selected prevention of cardiac events in patients with type 2 diabetes.
-
FDA approval · 2023-03-13FDA Approved: GLIPIZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for GLIPIZIDE from Aurobindo Pharma Limited. This action authorizes marketing of the generic gli…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study) [Phase 3]
Phase 3 trial investigating gemigliptin added to dapagliflozin and metformin in type 2 diabetes patients with inadequate glycemic control; s…
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Assessment of Dapagliflozin Effect on Diabetic Endothelial Dysfunction of Brachial Artery [Phase 4]
Phase 4 clinical trial assessing the effect of dapagliflozin on diabetic endothelial dysfunction in the brachial artery.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Regimen Education and Messaging in Diabetes (REMinD) [NA]
Clinical trial update on regimen education and messaging for type 2 diabetes focusing on medication adherence; study completed with results …
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial [Phase 4]
Phase 4 trial updating on expanded combination of evolocumab with empagliflozin for dyslipidemia in type 2 diabetes; study completed.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease [Phase 4]
Phase 4 trial update evaluating evolocumab in patients with diabetes and atherosclerotic vascular disease; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin. [Phase 3]
Phase 3 trial update evaluating DIDALA monotherapy versus metformin in type 2 diabetes, focusing on safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Cryovagotomy Diabetes Trial [NA]
Completed clinical trial update for Cryovagotomy Diabetes Trial; results posted in 2023. Conditions include Type 2 diabetes, diabetes mellit…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus [Phase 2]
A Phase 2 clinical trial update for HRS-7535 in adults with Type 2 Diabetes Mellitus is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing gemigliptin to glimepiride on cardiac diastolic function in type 2 diabetes patients.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) [Phase 3]
Phase 3 trial of mealtime insulin LY900014 in adults with type 2 diabetes using continuous glucose monitoring has completed and results post…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients [Phase 4]
Phase 4 trial comparing two hyperglycemia-correction scales in hospitalized patients.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update evaluating suvorexant for sleep disturbance in adults with chronic insomnia and suboptimally controlled type 2…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Impact of Periodontal Therapy on Patients With Diabetes [Phase 2]
Phase 2 trial evaluating whether periodontal therapy affects outcomes in patients with type 2 diabetes and periodontitis; study completed wi…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Continuous Glucose Monitoring in Diabetes and Prediabetes [NA]
Clinical trial update on continuous glucose monitoring in diabetes and prediabetes; completed with posted results.
-
FDA approval · 2023-02-28FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) filed by Novo Nordisk.
-
FDA approval · 2023-02-28FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product (brand NovoLOG Mix 70/30) from…